TOPICAL FORMULATIONS AND USES THEREOF
First Claim
Patent Images
1. An ophthalmic formulation, comprising (a) a receptor tyrosine kinase (RTK) inhibitor, and (b) a polyoxyl lipid or fatty acid.
2 Assignments
0 Petitions
Accused Products
Abstract
Provided herein include formulations for topical administration, such as ophthalmic formulations, and methods of using such formulations. In some aspects and embodiments the formulations may include a polyoxyl lipid or fatty acid, and or a polyalkoxylated alcohol and may include nanomicelles. Also included are methods of treating or preventing diseases or conditions, such as ocular diseases or conditions.
-
Citations
20 Claims
- 1. An ophthalmic formulation, comprising (a) a receptor tyrosine kinase (RTK) inhibitor, and (b) a polyoxyl lipid or fatty acid.
-
19. A method of manufacturing an ophthalmic formulation comprising liquefying/melting and mixing (a) a polyoxyl lipid or fatty acid, (b) a polyalkoxylated alcohol and (c) an active agent and subsequently adding a buffer and saline.
Specification